Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control...
Shree Ganesh Remedies reported revenue of 1.07 billion INR for fiscal year 2025, down 15.4% from fiscal year 2024, and net income of 230.68 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 211.07 million INR, down 22.0% from a year before. Its market capitalization was 8.75 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
No profile data available.